{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T19:05:27Z","timestamp":1778958327420,"version":"3.51.4"},"reference-count":70,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T00:00:00Z","timestamp":1771372800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002999","name":"Ministerie van Volksgezondheid, Welzijn en Sport","doi-asserted-by":"publisher","award":["2019-8"],"award-info":[{"award-number":["2019-8"]}],"id":[{"id":"10.13039\/501100002999","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010665","name":"EU Framework Programme for Research and Innovation Marie Sk\u0142odowska-Curie Actions","doi-asserted-by":"publisher","award":["101034290"],"award-info":[{"award-number":["101034290"]}],"id":[{"id":"10.13039\/100010665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004622","name":"KWF Kankerbestrijding","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004622","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007065","name":"Nvidia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejradiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Radiology"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.ejrad.2026.112738","type":"journal-article","created":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T00:17:10Z","timestamp":1771460230000},"page":"112738","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Concurrent driver mutations induce distinct tumour morphologies on radiological imaging"],"prefix":"10.1016","volume":"198","author":[{"given":"Diana Ivonne","family":"Rodr\u00edguez S\u00e1nchez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thera","family":"Vanneste","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julian","family":"Middelkoop","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olga","family":"Maxouri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sajjad","family":"Rostami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephan","family":"Ursprung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nino","family":"Boveradze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kalina","family":"Chupetlovska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Castagnoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federica","family":"Landolfi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eun Kyoung","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea Delli","family":"Pizzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolo","family":"Gennaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Petur","family":"Snaebjornsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zuhir","family":"Bodalal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8533-5090","authenticated-orcid":false,"given":"Regina","family":"Beets-Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"16","key":"10.1016\/j.ejrad.2026.112738_b0005","article-title":"Current status and future prospects of molecular imaging in targeting the tumor immune microenvironment","volume":"22","author":"Wang","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejrad.2026.112738_b0010","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13112557","article-title":"Transformational role of medical imaging in (radiation) oncology","author":"Coolens","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ejrad.2026.112738_b0015","doi-asserted-by":"crossref","unstructured":"Mariotti F, Agostini A, Borgheresi A, Marchegiani M, Zannotti A, Giacomelli G, et al. Insights into radiomics: a comprehensive review for beginners. Clin Transl Oncol [Internet]. 2025 May 12; Available from: http:\/\/dx.doi.org\/10.1007\/s12094-025-03939-5.","DOI":"10.1007\/s12094-025-03939-5"},{"key":"10.1016\/j.ejrad.2026.112738_b0020","doi-asserted-by":"crossref","unstructured":"Bodalal Z, Wamelink I, Trebeschi S, Beets-Tan RGH. Radiomics in immuno-oncology. Immunooncol Technol. 2021 Mar;9(100028):100028.","DOI":"10.1016\/j.iotech.2021.100028"},{"issue":"8","key":"10.1016\/j.ejrad.2026.112738_b0025","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.1007\/s00261-022-03534-0","article-title":"Identifying high-risk colon cancer on CT an a radiomics signature improve radiologist\u2019s performance for T staging?","volume":"47","author":"Hong","year":"2022","journal-title":"Abdom Radiol (NY)."},{"issue":"12","key":"10.1016\/j.ejrad.2026.112738_b0030","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.3390\/cancers13123015","article-title":"Systematic review on the association of radiomics with tumor biological endpoints","volume":"13","author":"La Greca","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"16","key":"10.1016\/j.ejrad.2026.112738_b0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e36313","article-title":"Systematic review and meta-analysis on the classification metrics of machine learning algorithm based radiomics in hepatocellular carcinoma diagnosis","volume":"10","author":"Mohd Haniff","year":"2024","journal-title":"Heliyon"},{"issue":"6","key":"10.1016\/j.ejrad.2026.112738_b0040","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1007\/s00261-019-02028-w","article-title":"Radiogenomics: bridging imaging and genomics","volume":"44","author":"Bodalal","year":"2019","journal-title":"Abdom Radiol (NY)."},{"key":"10.1016\/j.ejrad.2026.112738_b0045","doi-asserted-by":"crossref","unstructured":"Filippi L, Urso L, Manco L, Olivieri M, Badrane I, Evangelista L. Insights into pet-based radiogenomics in oncology: an updated systematic review. Eur J Nucl Med Mol Imaging [Internet]. 2025 Apr 7; Available from: http:\/\/dx.doi.org\/10.1007\/s00259-025-07262-7.","DOI":"10.1007\/s00259-025-07262-7"},{"issue":"1","key":"10.1016\/j.ejrad.2026.112738_b0050","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s13244-023-01474-x","article-title":"Radiomic signatures from T2W and DWI MRI are predictive of tumour hypoxia in colorectal liver metastases","volume":"14","author":"Bodalal","year":"2023","journal-title":"Insights Imaging."},{"issue":"1","key":"10.1016\/j.ejrad.2026.112738_b0055","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1186\/s13244-024-01831-4","article-title":"The prognostic value of radiogenomics using CT in patients with lung cancer: a systematic review","volume":"15","author":"Jiang","year":"2024","journal-title":"Insights Imaging."},{"issue":"1","key":"10.1016\/j.ejrad.2026.112738_b0060","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s41747-024-00484-8","article-title":"Non-invasive CT radiomic biomarkers predict microsatellite stability status in colorectal cancer: a multicenter validation study","volume":"8","author":"Bodalal","year":"2024","journal-title":"Eur Radiol Exp."},{"issue":"108389","key":"10.1016\/j.ejrad.2026.112738_b0065","article-title":"Overcoming data scarcity in radiomics\/radiogenomics using synthetic radiomic features","volume":"174","author":"Ahmadian","year":"2024","journal-title":"Comput. Biol. Med."},{"issue":"2","key":"10.1016\/j.ejrad.2026.112738_b0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2018.03.035","article-title":"Oncogenic signaling pathways in the Cancer Genome Atlas","volume":"173","author":"Sanchez-Vega","year":"2018","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.ejrad.2026.112738_b0075","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1186\/s12943-024-02173-x","article-title":"Co-occurring mutations identify prognostic subgroups of microsatellite stable colorectal cancer","volume":"23","author":"Nunes","year":"2024","journal-title":"Mol. Cancer"},{"issue":"2","key":"10.1016\/j.ejrad.2026.112738_b0080","doi-asserted-by":"crossref","first-page":"415","DOI":"10.3390\/cancers14020415","article-title":"Comprehensive analysis of co-mutations identifies cooperating mechanisms of tumorigenesis","volume":"14","author":"Jiang","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"14","key":"10.1016\/j.ejrad.2026.112738_b0085","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.3390\/cancers17142388","article-title":"Co-occurring genomic alterations in NSCLC: making order into a crowded list","volume":"17","author":"Attili","year":"2025","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.ejrad.2026.112738_b0090","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/s41392-023-01347-1","article-title":"Targeting p53 pathways: mechanisms, structures, and advances in therapy","volume":"8","author":"Wang","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"issue":"4","key":"10.1016\/j.ejrad.2026.112738_b0095","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1038\/s41591-024-02903-0","article-title":"Targeting KRAS in cancer","volume":"30","author":"Singhal","year":"2024","journal-title":"Nat. Med."},{"issue":"11","key":"10.1016\/j.ejrad.2026.112738_b0100","doi-asserted-by":"crossref","first-page":"2748","DOI":"10.3390\/cancers13112748","article-title":"EGFR in cancer: Signaling mechanisms, drugs, and acquired resistance","volume":"13","author":"Uribe","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"3","key":"10.1016\/j.ejrad.2026.112738_b0105","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/s10555-025-10272-4","article-title":"Shaping the battlefield: EGFR and KRAS tumor mutations\u2019 role on the immune microenvironment and immunotherapy responses in lung cancer","volume":"44","author":"Alsaed","year":"2025","journal-title":"Cancer Metastasis Rev."},{"issue":"4","key":"10.1016\/j.ejrad.2026.112738_b0110","article-title":"Evidence that synthetic lethality underlies the mutual exclusivity of oncogenic KRAS and EGFR mutations in lung adenocarcinoma","volume":"5","author":"Unni","year":"2015","journal-title":"Elife"},{"issue":"1","key":"10.1016\/j.ejrad.2026.112738_b0115","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s13244-023-01415-8","article-title":"CheckList for EvaluAtion of Radiomics research (CLEAR): a step-by-step reporting guideline for authors and reviewers endorsed by ESR and EuSoMII","volume":"14","author":"Kocak","year":"2023","journal-title":"Insights Imaging."},{"key":"10.1016\/j.ejrad.2026.112738_b0120","unstructured":"Welcome to pyradiomics documentation! \u2014 pyradiomics v3.1.0rc2.post5+g6a761c4 documentation [Internet]. [cited 2025 Jul 24]. Available from: https:\/\/pyradiomics.readthedocs.io\/en\/latest\/."},{"issue":"2","key":"10.1016\/j.ejrad.2026.112738_b0125","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1148\/radiol.2020191145","article-title":"The image biomarker standardization initiative: Standardized quantitative radiomics for high-throughput image-based phenotyping","volume":"295","author":"Zwanenburg","year":"2020","journal-title":"Radiology"},{"issue":"21","key":"10.1016\/j.ejrad.2026.112738_b0130","doi-asserted-by":"crossref","DOI":"10.1158\/0008-5472.CAN-17-0339","article-title":"Computational radiomics system to decode the radiographic phenotype","volume":"77","author":"van Griethuysen","year":"2017","journal-title":"Cancer Res."},{"issue":"17","key":"10.1016\/j.ejrad.2026.112738_b0135","doi-asserted-by":"crossref","first-page":"4267","DOI":"10.2147\/IJGM.S479978","article-title":"Combined CT-based radiomics and clinic-radiological characteristics for preoperative differentiation of solitary-type invasive mucinous and non-mucinous lung adenocarcinoma","volume":"21","author":"Hong","year":"2024","journal-title":"Int J Gen Med."},{"key":"10.1016\/j.ejrad.2026.112738_b0140","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.lungcan.2020.02.018","article-title":"Stable and discriminating radiomic predictor of recurrence in early stage non-small cell lung cancer: Multi-site study","volume":"142","author":"Khorrami","year":"2020","journal-title":"Lung Cancer"},{"issue":"1","key":"10.1016\/j.ejrad.2026.112738_b0145","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1158\/2326-6066.CIR-19-0476","article-title":"Changes in CT radiomic features associated with lymphocyte distribution predict overall survival and response to immunotherapy in non-small cell lung cancer","volume":"8","author":"Khorrami","year":"2020","journal-title":"Cancer Immunol. Res."},{"issue":"5","key":"10.1016\/j.ejrad.2026.112738_b0150","article-title":"Radiomics and quantitative multi-parametric MRI for predicting uterine fibroid growth","volume":"11","author":"Drukker","year":"2024","journal-title":"J Med Imaging (bellingham)."},{"issue":"11","key":"10.1016\/j.ejrad.2026.112738_b0155","article-title":"MRI-based radiomics models for predicting risk classification of gastrointestinal stromal tumors","volume":"10","author":"Mao","year":"2021","journal-title":"Front. Oncol."},{"issue":"2","key":"10.1016\/j.ejrad.2026.112738_b0160","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/joim.20106","article-title":"The TP53 tumor suppressor gene: from molecular biology to clinical investigations","volume":"298","author":"Baliakas","year":"2025","journal-title":"J. Intern. Med."},{"issue":"10","key":"10.1016\/j.ejrad.2026.112738_b0165","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1113205","article-title":"Intratumor heterogeneity and branched evolution revealed by multiregion sequencing","volume":"366","author":"Gerlinger","year":"2012","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.ejrad.2026.112738_b0170","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1186\/s12885-021-08569-y","article-title":"Radiomic assessment as a method for predicting tumor mutation burden (TMB) of bladder cancer patients: a feasibility study","volume":"21","author":"Tang","year":"2021","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.ejrad.2026.112738_b0175","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s12880-024-01221-8","article-title":"CT radiomics-based model for predicting TMB and immunotherapy response in non-small cell lung cancer","volume":"24","author":"Wang","year":"2024","journal-title":"BMC Med. Imaging"},{"issue":"7","key":"10.1016\/j.ejrad.2026.112738_b0180","article-title":"Subsolid pulmonary nodules: Controversy and perspective","volume":"4","author":"Hammer","year":"2020","journal-title":"Eur J Radiol Open."},{"issue":"12","key":"10.1016\/j.ejrad.2026.112738_b0185","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1093\/jjco\/hym139","article-title":"Molecular markers and changes of computed tomography appearance in lung adenocarcinoma with ground-glass opacity","volume":"37","author":"Yoshida","year":"2007","journal-title":"Jpn. J. Clin. Oncol."},{"issue":"10","key":"10.1016\/j.ejrad.2026.112738_b0190","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1038\/modpathol.2013.74","article-title":"KRAS mutations are associated with solid growth pattern and tumor-infiltrating leukocytes in lung adenocarcinoma","volume":"26","author":"Rekhtman","year":"2013","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.ejrad.2026.112738_b0195","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1038\/modpathol.2011.151","article-title":"Assessment of invasion in lung adenocarcinoma classification, including adenocarcinoma in situ and minimally invasive adenocarcinoma","volume":"25 Suppl 1(S1)","author":"Borczuk","year":"2012","journal-title":"Mod. Pathol."},{"issue":"3","key":"10.1016\/j.ejrad.2026.112738_b0200","doi-asserted-by":"crossref","first-page":"320","DOI":"10.2353\/jmoldx.2007.060182","article-title":"Mucinous differentiation correlates with absence of EGFR mutation and presence of KRAS mutation in lung adenocarcinomas with bronchioloalveolar features","volume":"9","author":"Finberg","year":"2007","journal-title":"J. Mol. Diagn."},{"issue":"1","key":"10.1016\/j.ejrad.2026.112738_b0205","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s12885-025-13424-5","article-title":"Estimation of TP53 mutations for endometrial cancer based on diffusion-weighted imaging deep learning and radiomics features","volume":"25","author":"Shen","year":"2025","journal-title":"BMC Cancer"},{"issue":"5","key":"10.1016\/j.ejrad.2026.112738_b0210","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.21037\/tlcr-2024-1196","article-title":"Deep learning in histopathology images for prediction of oncogenic driver molecular alterations in lung cancer: a systematic review and meta-analysis","volume":"14","author":"Parra-Medina","year":"2025","journal-title":"Transl Lung Cancer Res."},{"key":"10.1016\/j.ejrad.2026.112738_b0215","doi-asserted-by":"crossref","unstructured":"http:\/\/dx.doi.org\/10.3390\/cancers13081814.","DOI":"10.3390\/cancers13081814"},{"issue":"7","key":"10.1016\/j.ejrad.2026.112738_b0220","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.1016\/j.acra.2024.01.031","article-title":"Contrast Enhanced CT Radiogenomics in a Retrospective NSCLC Cohort: Models, Attempted Validation of a published Model and the Relevance of the Clinical Context","volume":"31","author":"Kohan","year":"2024","journal-title":"Acad. Radiol."},{"key":"10.1016\/j.ejrad.2026.112738_b0225","doi-asserted-by":"crossref","unstructured":"Fuster-Matanzo A, Pic\u00f3-Peris A, Bellv\u00eds-Bataller F, Jimenez-Pastor A, Weiss GJ, Mart\u00ed-Bonmat\u00ed L, et al. Prediction of oncogene mutation status in non-small cell lung cancer: a systematic review and meta-analysis with a special focus on artificial intelligence-based methods. Eur Radiol [Internet]. 2025 Sep 8; Available from: http:\/\/dx.doi.org\/10.1007\/s00330-025-11962-x.","DOI":"10.1101\/2024.05.31.24308261"},{"issue":"10","key":"10.1016\/j.ejrad.2026.112738_b0230","article-title":"Effect of TP53 deficiency and KRAS signaling on the bioenergetics of colon cancer cells in response to different substrates: a single cell study","volume":"27","author":"Kealey","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"issue":"3","key":"10.1016\/j.ejrad.2026.112738_b0235","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/s41416-024-02746-z","article-title":"KRAS and TP53 co-mutation predicts benefit of immune checkpoint blockade in lung adenocarcinoma","volume":"131","author":"Budczies","year":"2024","journal-title":"Br. J. Cancer"},{"issue":"27","key":"10.1016\/j.ejrad.2026.112738_b0240","doi-asserted-by":"crossref","first-page":"3031","DOI":"10.2217\/fon-2022-0295","article-title":"Non-small-cell lung cancer patients harboring TP53\/KRAS co-mutation could benefit from a PD-L1 inhibitor","volume":"18","author":"Zhang","year":"2022","journal-title":"Future Oncol."},{"issue":"8","key":"10.1016\/j.ejrad.2026.112738_b0245","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1158\/2159-8290.CD-14-1236","article-title":"Co-occurring genomic alterations define major subsets of KRAS-mutant lung adenocarcinoma with distinct biology, immune profiles, and therapeutic vulnerabilities","volume":"5","author":"Skoulidis","year":"2015","journal-title":"Cancer Discov."},{"key":"10.1016\/j.ejrad.2026.112738_b0250","doi-asserted-by":"crossref","unstructured":"Motta L, Molinari F, Pankovics J, Pedrazzini B, Valera A, Epistolio S, et al. Prognostic Impact of KRAS-TP53 Co-Mutations in Patients with Early-Stage Non-Small Cell Lung Cancer: A Single-Center Retrospective Study. J Clin Med [Internet]. 2025 Jul 19;14(14). Available from: http:\/\/dx.doi.org\/10.3390\/jcm14145135.","DOI":"10.3390\/jcm14145135"},{"issue":"8","key":"10.1016\/j.ejrad.2026.112738_b0255","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1002\/ijc.30591","article-title":"KRAS mutation coupled with p53 loss is sufficient to induce ovarian carcinosarcomas in mice","volume":"140","author":"Tang","year":"2017","journal-title":"Int. J. Cancer"},{"issue":"9","key":"10.1016\/j.ejrad.2026.112738_b0260","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1002\/ijc.33756","article-title":"Definitive evidence for Club cells as progenitors for mutant Kras\/Trp53-deficient lung cancer","volume":"149","author":"Rosigkeit","year":"2021","journal-title":"Int. J. Cancer"},{"issue":"1","key":"10.1016\/j.ejrad.2026.112738_b0265","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1148\/radiol.2016160259","article-title":"Radiogenomic analysis demonstrates associations between (18)F-fluoro-2-deoxyglucose PET, prognosis, and epithelial-mesenchymal transition in non-small cell lung cancer","volume":"280","author":"Yamamoto","year":"2016","journal-title":"Radiology"},{"issue":"1","key":"10.1016\/j.ejrad.2026.112738_b0270","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1148\/radiology.215.1.r00mr2989","article-title":"Perilesional enhancement of hepatic metastases: correlation between MR imaging and histopathologic findings-initial observations","volume":"215","author":"Semelka","year":"2000","journal-title":"Radiology"},{"issue":"12","key":"10.1016\/j.ejrad.2026.112738_b0275","doi-asserted-by":"crossref","first-page":"683","DOI":"10.3349\/ymj.2024.0062","article-title":"Mutation-driven immune microenvironments in non-small cell lung cancer: Unrevealing patterns through cluster analysis","volume":"65","author":"Kim","year":"2024","journal-title":"Yonsei Med. J."},{"issue":"3","key":"10.1016\/j.ejrad.2026.112738_b0280","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1083\/jcb.200905057","article-title":"Proliferation of aneuploid human cells is limited by a p53-dependent mechanism","volume":"188","author":"Thompson","year":"2010","journal-title":"J. Cell Biol."},{"issue":"1","key":"10.1016\/j.ejrad.2026.112738_b0285","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/s41392-024-01767-7","article-title":"The two sides of chromosomal instability: drivers and brakes in cancer","volume":"9","author":"Hosea","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"issue":"1","key":"10.1016\/j.ejrad.2026.112738_b0290","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1186\/s12885-021-08811-7","article-title":"Whole genome copy number analyses reveal a highly aberrant genome in TP53 mutant lung adenocarcinoma tumors","volume":"21","author":"Bjaan\u00e6s","year":"2021","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.ejrad.2026.112738_b0295","doi-asserted-by":"crossref","first-page":"3625","DOI":"10.1038\/s41598-020-60202-3","article-title":"Identifying relationships between imaging phenotypes and lung cancer-related mutation status: EGFR and KRAS","volume":"10","author":"Pinheiro","year":"2020","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.ejrad.2026.112738_b0300","doi-asserted-by":"crossref","DOI":"10.1148\/rycan.220153","article-title":"Current status of Cancer Genomics and imaging phenotypes: what radiologists need to know","volume":"5","author":"Mendes Serr\u00e3o","year":"2023","journal-title":"Radiol. Imaging Cancer"},{"key":"10.1016\/j.ejrad.2026.112738_b0305","unstructured":"."},{"key":"10.1016\/j.ejrad.2026.112738_b0310","doi-asserted-by":"crossref","unstructured":"Liu Y \u2019e, Luo X, Yang L, Cheng X, Zhu X, Zhang H, et al. Progression-free survival prediction model based on AI-enhanced dynamic radiomics for personalized EGFR-TKI treatment monitoring patients with lung adenocarcinoma. Thorac Cancer. 2025 Mar;16(6):e70010.","DOI":"10.1111\/1759-7714.70010"},{"issue":"7","key":"10.1016\/j.ejrad.2026.112738_b0315","doi-asserted-by":"crossref","first-page":"545","DOI":"10.21037\/atm-20-6473","article-title":"A computed tomography (CT)-derived radiomics approach for predicting primary co-mutations involving and epidermal growth factor receptor in patients with advanced lung adenocarcinomas (LUAD)","volume":"9","author":"Zhu","year":"2021","journal-title":"Ann Transl Med."},{"key":"10.1016\/j.ejrad.2026.112738_b0320","unstructured":"https:\/\/pubmed.ncbi.nlm.nih.gov\/39319553\/."},{"key":"10.1016\/j.ejrad.2026.112738_b0325","doi-asserted-by":"crossref","unstructured":"Bridging AI research and clinical impact. European Journal of Radiology Artificial Intelligence. 2025 Jun 1;2:100026.","DOI":"10.1016\/j.ejrai.2025.100026"},{"key":"10.1016\/j.ejrad.2026.112738_b0330","doi-asserted-by":"crossref","unstructured":"Rethinking radio-genomics: Pitfalls in multi-omics integration involving radiomics. European Journal of Radiology Artificial Intelligence. 2025 Jun 1;2:100012.","DOI":"10.1016\/j.ejrai.2025.100012"},{"key":"10.1016\/j.ejrad.2026.112738_b0335","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.ebiom.2019.01.050","article-title":"Biomarker concordance between primary colorectal cancer and its metastases","volume":"40","author":"Bhullar","year":"2019","journal-title":"EBioMedicine"},{"issue":"6","key":"10.1016\/j.ejrad.2026.112738_b0340","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0218414","article-title":"Discordance of epidermal growth factor receptor mutation between primary lung tumor and paired distant metastases in non-small cell lung cancer: a systematic review and meta-analysis","volume":"14","author":"Lee","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.ejrad.2026.112738_b0345","doi-asserted-by":"crossref","unstructured":"Xu Y, Lu L, Sun SH, E LN, Lian W, Yang H, et al. Effect of CT image acquisition parameters on diagnostic performance of radiomics in predicting malignancy of pulmonary nodules of different sizes. Eur Radiol. 2022 Mar;32(3):1517\u201327.","DOI":"10.1007\/s00330-021-08274-1"},{"issue":"1","key":"10.1016\/j.ejrad.2026.112738_b0350","doi-asserted-by":"crossref","first-page":"16712","DOI":"10.1038\/s41598-022-20703-9","article-title":"Robustness of radiomics to variations in segmentation methods in multimodal brain MRI","volume":"12","author":"Poirot","year":"2022","journal-title":"Sci. Rep."}],"container-title":["European Journal of Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0720048X26000860?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0720048X26000860?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T18:04:12Z","timestamp":1777572252000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0720048X26000860"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":70,"alternative-id":["S0720048X26000860"],"URL":"https:\/\/doi.org\/10.1016\/j.ejrad.2026.112738","relation":{},"ISSN":["0720-048X"],"issn-type":[{"value":"0720-048X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Concurrent driver mutations induce distinct tumour morphologies on radiological imaging","name":"articletitle","label":"Article Title"},{"value":"European Journal of Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejrad.2026.112738","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"112738"}}